What is KidneyX?
The Kidney Innovation Accelerator (KidneyX) is a public-private partnership between the U.S. Department of Health and Human Services and the American Society of Nephrology to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.
KidneyX seeks to improve the lives of the 850 million people currently affected worldwide by accelerating the development of drugs, devices, biologics and other therapies across the spectrum of kidney care including: Prevention, Diagnostics and Treatment.
“We aim to “de-risk” innovation by streamlining processes, reducing regulatory barriers, and modernizing the way we pay for treatment. This is going to require innovation from outside the government. We plan to stimulate and accelerate innovation through a series of cash prize competitions.” -Ed Simcox, Chief Technology Officer, U.S. Department of Health and Human Services.
How will KidneyX Succeed?
Building off the success of similar public-private accelerators, KidneyX will engage a community of researchers, innovators, and investors to bring breakthrough therapies to patients by:
Driving patient access to disruptive technologies via competitive, merit-based prize funding to innovators.
Providing a clearer and less expensive path to bringing products to patients and their families.
Creating a sense of urgency by spotlighting the immediate needs of patients and their families.
KidneyX’s first round of prize funding will focus on accelerating the commercialization of next-generation dialysis products.
The Redesign Dialysis prize will run in two phases with a total prize purse of $2,625,000. The first phase, which will award up to 15 prizes of $75,000 each, launching in late October and running through February 2019 asks participants to design solutions or components of solutions that can replicate normal kidney functions and improve patient quality of life. The second phase, planned to run from April 2019 to January 2020, will ask participants to develop initial prototypes; this phase will award up to 3 prizes of $500,000 each. Participants may compete in the second phase even if they do not submit a solution in the first phase.
Submission for the Redesign Dialysis prize will officially open on October 25, 2018. More information on how to apply will be provided in the coming weeks. Information on eligibility and submission requirements can be found in the prize announcement. A ‘Frequently Asked Questions” document will be provided in the coming weeks as well.
Dates for KidneyX: Redesign Dialysis, Phase 1
Submission period begins: October 25, 2018
Submission period ends: February 28, 2019, 5:00 p.m. ET
Awardees announced by: April 30, 2019
Dates for KidneyX: Redesign Dialysis, Phase 2
Submission period begins: September 18, 2019
Submission period ends: January 31, 2020, 5:00 p.m. ET
Awardees announced by: March 27, 2020
Redesign Dialysis Phase 3 has been announced for 2020. There will be changes made to the announcement, based on the Artificial Kidney RFI, closer to the submission period. Preliminary details can be found here.